CoChat

Comparison of insulin degludec with insulin detemir in type 1 diabetes: a 1‐year treat‐to‐target trial

Davies, M., Sasaki, T., Gross, J. L., Bantwal, G., Ono, Y., Nishida, T., Tojjar, D., Seino, H. · 2016 · Diabetes, Obesity and Metabolism
Cited by 33

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

The long‐term safety and tolerability of insulin degludec ( IDeg ) was compared with that of insulin detemir ( IDet ), as basal treatment in participants with type 1 diabetes mellitus ( T1DM ). In the present multinational, 26‐week core + 26‐week extension, controlled, open‐label, parallel‐group trial, adults with T1DM were randomized to IDeg or IDet as basal insulin treatment combined with meal‐time bolus insulin aspart. IDeg was administered once daily, whilst IDet was administered once or twice daily depending on patients' glycaemic control. After 1 year, IDeg provided a 33% lower rate of nocturnal hypoglycaemia compared with IDet : estimated rate ratio ( IDeg : IDet ) 0.67 [95% confidence interval ( CI ) 0.51; 0.88]; p < 0.05. IDeg improved glycated haemoglobin after 1 year of treatment, similarly to IDet , but IDeg also provided a significantly greater reduction in fasting plasma glucose compared with IDet : estimated difference ( IDeg − IDet ) −1.11 (95% CI −1.83; −0.40) mmol/l; p < 0.05. The present study confirmed the long‐term safety and tolerability profile of IDeg in patients with T1DM . IDeg provided a lower risk of nocturnal confirmed hypoglycaemia than IDet .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.12573

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 33

Metadata

Authors
Davies, M., Sasaki, T., Gross, J. L., Bantwal, G., Ono, Y., Nishida, T., Tojjar, D., & Seino, H.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2015-10-19
Volume
18
Issue
1
Pages
96-99
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2108937883
Cited by
33
References
2
FWCI
2.03
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.